ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,582.43
0.59%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) 뉴스

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OPRX
일자시간출처헤드라인심볼기업
2024/06/1206:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/06/1206:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/06/1022:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPRXOptimizeRx Corporation
2024/06/0805:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2024/05/1606:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPRXOptimizeRx Corporation
2024/05/1505:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2024/05/0710:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/05/0710:34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
2024/05/0710:32Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
2024/03/1206:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2024/03/0706:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/02/2208:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/02/2208:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/02/2208:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/02/2208:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/02/1507:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
2024/02/1408:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/01/2706:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2024/01/1207:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/01/1006:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPRXOptimizeRx Corporation
2024/01/0607:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPRXOptimizeRx Corporation
2023/12/3007:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
2023/11/2906:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
2023/11/1404:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2023/11/0621:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2023/11/0323:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2023/10/3105:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
2023/10/2605:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2023/10/1705:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
2023/10/1303:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
 검색 관련기사 보기:NASDAQ:OPRX

최근 히스토리

NASDAQ
NVDA
NVIDIA
COIN
SOLUSD
Solana
NYSE
MRK
Merck
NYSE
BAC
Bank of America
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
USI
USTECH100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유